Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Unlike GLP-1 agonists that work primarily through incretin pathways, cagrilintide provides complementary satiety signaling through amylin receptors in the area postrema (AP) and nucleus tractus solitarius (NTS) of the brainstem
Cagrilintides dose-dependent weight loss in both rodent models and human Phase 2 trials, combined with its dependence on AMYR/AMYR rather than CTR alone, supports a receptor-specific mechanism distinct from calcitonin-driven effects. The following comparison table summarizes cagrilintide alongside related peptides investigated in metabolic research models: Cagrilintide is studied for neuroendocrine signaling pathways, with particular focus on how amylin receptor activation in the central nervous system modulates appetite and energy balance
Lin J, Liao X, Zhang J, Du G, Chen J
It affects concentration, vial longevity, waste, and cost efficiency
